Xiamen Solex High-Tech Industries (603992.SH): Songlin Investment plans to increase its stake in the company by 20 million to 40 million yuan.

21:12 12/03/2026

Songlin Technology (603992.SH) has announced that, based on its confidence in the company's future stable development and long-term investment value, to enhance investor confidence, the company's actual controller and concerted action person, Songlin Investment, intends to increase its holdings of the company's shares through centralized bidding trading on the Shanghai Stock Exchange system within 6 months from the disclosure date of this announcement, with a total amount of not less than 20 million yuan (inclusive) and not more than 40 million yuan (inclusive), with funds coming from its own and self-raised funds.

Xiamen Solex High-Tech Industries (603992.SH) announced that, based on its confidence in the company's future stable development and long-term investment value, to enhance investor confidence, the company's controlling shareholder and concerted action party, Songlin Investment, intends to increase its holdings of the company's shares through centralized bidding trading on the Shanghai Stock Exchange system within 6 months from the disclosure date of this announcement. The total amount of the increase shall not be less than 20 million yuan (inclusive) and not exceed 40 million yuan (inclusive), with the funds coming from its own and self-raised funds.

PROSP INV HOLD (00310) has subscribed 612,000 Hong Kong dollars for the shares of the listed company. Trading will resume on March 13th.

VISEN PHARMA-B(02561) released its annual performance, with research and development costs reaching 93.48 million yuan, an increase of 3.27% year-on-year.

US Stock Market Move | Himax Technologies, Inc. Sponsored ADR (HIMX.US) soared over 23% in early trading, accumulating a 52% increase over the past 4 trading days.

PROSP INV HOLD (00310) has subscribed 612,000 Hong Kong dollars for the shares of the listed company. Trading will resume on March 13th.

VISEN PHARMA-B(02561) released its annual performance, with research and development costs reaching 93.48 million yuan, an increase of 3.27% year-on-year.

US Stock Market Move | Himax Technologies, Inc. Sponsored ADR (HIMX.US) soared over 23% in early trading, accumulating a 52% increase over the past 4 trading days.